Prevalence of post-traumatic stress disorder symptoms in patients with mental disorders during the COVID-19 pandemic

This article was originally published here

BMC Psychiatry. 2022 Mar 1;22(1):156. doi: 10.1186/s12888-022-03790-w.

ABSTRACT

BACKGROUND: The outbreak of the COVID-19 pandemic has caused serious public health concerns, posing significant challenges to health services. A particular area of ​​concern is the mental health of patients with mental disorders, who are often an overlooked group. The aim of this study was to investigate the prevalence and associated factors of post-traumatic stress disorder (PTSD) symptoms among patients with mental disorders in China during the COVID-19 pandemic.

METHODS: Self-report questionnaires were distributed to patients at four psychiatric hospitals in Beijing, China, between April 28 and May 30, 2020. Information regarding sociodemographic characteristics, COVID-19-related factors, support, factors psychosomatic and PTSD symptoms were collected using a series of scales, such as the Revised Event Impact Scale, the 7-item Generalized Anxiety Disorder Scale, the from depression to 9-item patient health questionnaire, etc. Multivariate regression was used to identify factors related to PTSD symptoms.

RESULTS: A total of 1055 patients with mental disorders were included in the final sample. The prevalence of PTSD symptoms was 41.3%. Hierarchical linear regression demonstrated that pandemic fear and anxiety were shared associated factors for PTSD symptoms and their subscales. In addition, age was associated with symptoms of total PTSD (β = 0.12, p

CONCLUSIONS: The prevalence of PTSD symptoms was high among patients with mental disorders during the COVID-19 pandemic in China. This study found that age, fear of the pandemic, anxiety and depression are important associated factors of PTSD symptoms in patients with mental disorders during the pandemic. We call for greater awareness and introduction of interventions for PTSD to relieve psychological stress in these patients.

PMID:35232421 | DOI: 10.1186/s12888-022-03790-w

Comments are closed.